Subscribe To Our Free Newsletter |
Sun Pharma Q4 Preview: Profits may grow up to 41% on higher specialty sales
Sun Pharma is set to see a strong financial earnings on a year-on-year (Y-o-Y) basis for Q4FY23, showing a 8-14 per cent Y-o-Y jump in its topline